Defeng F. Pan

99 Huaihai West Road
Xuzhou, 221004, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 67 publications

Coronary microvascular dysfunction mediates in-hospital adverse outcomes in ST-segment elevation myocardial infarction patients without standard modifiable cardiovascular risk factors.

Coronary microvascular dysfunction mediates in-hospital adverse outcomes in ST-segment elevation myocardial infarction patients without standard modifiable cardiovascular risk factors.

Journal: Frontiers in cardiovascular medicine

Published: February 10, 2026

Identification of a peptide inhibitor disrupting the PCSK9-LDLR interaction via pharmacophore-based virtual screening, molecular dynamics simulations and in vitro/vivo evaluation.

Identification of a peptide inhibitor disrupting the PCSK9-LDLR interaction via pharmacophore-based virtual screening, molecular dynamics simulations and in vitro/vivo evaluation.

Journal: Journal of enzyme inhibition and medicinal chemistry

Published: January 22, 2026

The association between the C-reactive protein-triglyceride glucose index and myocardial injury after acute ischemic stroke: a machine learning analysis of the brain-heart axis.

The association between the C-reactive protein-triglyceride glucose index and myocardial injury after acute ischemic stroke: a machine learning analysis of the brain-heart axis.

Journal: Frontiers in cardiovascular medicine

Published: November 09, 2025

Association Between Albumin-Corrected Anion Gap and Mortality in ICU Patients With Acute Heart Failure: A MIMIC-IV Cohort Study.

Association Between Albumin-Corrected Anion Gap and Mortality in ICU Patients With Acute Heart Failure: A MIMIC-IV Cohort Study.

Journal: Cardiovascular therapeutics

Published: September 15, 2025

CysC as a predictor of left ventricular remodeling and major adverse cardiovascular events in patients with acute myocardial infarction.

CysC as a predictor of left ventricular remodeling and major adverse cardiovascular events in patients with acute myocardial infarction.

Journal: Frontiers in cardiovascular medicine

Published: September 03, 2025

The Combined Prognostic Value of the Systemic Immune-Inflammation Index and LDL-C in Patients with AMI Undergoing PPCI.

The Combined Prognostic Value of the Systemic Immune-Inflammation Index and LDL-C in Patients with AMI Undergoing PPCI.

Journal: Journal of inflammation research

Published: May 17, 2025

Stepwise Assessment of Computational Coronary Physiology and Plaque Vulnerability: Impact on Coronary Revascularization Decision Making.

Stepwise Assessment of Computational Coronary Physiology and Plaque Vulnerability: Impact on Coronary Revascularization Decision Making.

Journal: JACC. Asia

Published: May 06, 2025

Identification of risk factors for myocardial injury in acute ischemic stroke with diabetes mellitus: a retrospective cohort study on stroke-heart syndrome.

Identification of risk factors for myocardial injury in acute ischemic stroke with diabetes mellitus: a retrospective cohort study on stroke-heart syndrome.

Journal: Frontiers in stroke

Published: April 25, 2025

Does diabetes affect the incidence of non-target lesion revascularization? A meta-analysis of data from randomized controlled trials.

Does diabetes affect the incidence of non-target lesion revascularization? A meta-analysis of data from randomized controlled trials.

Journal: BMC endocrine disorders

Published: April 19, 2025

Machine learning-driven prediction of readmission risk in heart failure patients with diabetes: synergistic assessment of inflammatory and metabolic biomarkers.

Machine learning-driven prediction of readmission risk in heart failure patients with diabetes: synergistic assessment of inflammatory and metabolic biomarkers.

Journal: International journal of cardiology

Published: April 10, 2025

A new online dynamic nomogram based on the inflammation burden index to predict cardiac injury after antitumor therapy in lung cancer patients.

A new online dynamic nomogram based on the inflammation burden index to predict cardiac injury after antitumor therapy in lung cancer patients.

Journal: Cardio-oncology (London, England)

Published: January 18, 2025

Relaxin Inhibits Angiotensin II-Induced Cardiac Fibrosis by Activating NO/cGMP Signaling Pathway.

Relaxin Inhibits Angiotensin II-Induced Cardiac Fibrosis by Activating NO/cGMP Signaling Pathway.

Journal: Anatolian journal of cardiology

Published: December 20, 2024

Showing 1-12 of 67

Last Updated: 09/26/2026